FR2551436B1 - 16-fluoro-16,17-dideshydro-prostanoides, procede pour leur preparation, produits intermediaires de leur preparation et leurs utilisations therapeutiques, notamment dans les indications des prostaglandines naturelles - Google Patents

16-fluoro-16,17-dideshydro-prostanoides, procede pour leur preparation, produits intermediaires de leur preparation et leurs utilisations therapeutiques, notamment dans les indications des prostaglandines naturelles

Info

Publication number
FR2551436B1
FR2551436B1 FR8413013A FR8413013A FR2551436B1 FR 2551436 B1 FR2551436 B1 FR 2551436B1 FR 8413013 A FR8413013 A FR 8413013A FR 8413013 A FR8413013 A FR 8413013A FR 2551436 B1 FR2551436 B1 FR 2551436B1
Authority
FR
France
Prior art keywords
preparation
prostanoides
dideshydro
intermediates
indications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8413013A
Other languages
English (en)
Other versions
FR2551436A1 (fr
Inventor
Franco Faustini
Roberto D Alessio
Achille Panzeri
Enrico Di Salle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Publication of FR2551436A1 publication Critical patent/FR2551436A1/fr
Application granted granted Critical
Publication of FR2551436B1 publication Critical patent/FR2551436B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
FR8413013A 1983-09-07 1984-08-21 16-fluoro-16,17-dideshydro-prostanoides, procede pour leur preparation, produits intermediaires de leur preparation et leurs utilisations therapeutiques, notamment dans les indications des prostaglandines naturelles Expired FR2551436B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838324004A GB8324004D0 (en) 1983-09-07 1983-09-07 16-fluoro-16 17-didehydro prostanoids

Publications (2)

Publication Number Publication Date
FR2551436A1 FR2551436A1 (fr) 1985-03-08
FR2551436B1 true FR2551436B1 (fr) 1987-02-27

Family

ID=10548451

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8413013A Expired FR2551436B1 (fr) 1983-09-07 1984-08-21 16-fluoro-16,17-dideshydro-prostanoides, procede pour leur preparation, produits intermediaires de leur preparation et leurs utilisations therapeutiques, notamment dans les indications des prostaglandines naturelles

Country Status (24)

Country Link
US (1) US4626597A (fr)
JP (1) JPS6072859A (fr)
KR (1) KR850002830A (fr)
AU (1) AU562725B2 (fr)
BE (1) BE900414A (fr)
CH (1) CH662114A5 (fr)
CS (1) CS259869B2 (fr)
DE (1) DE3430626A1 (fr)
DK (1) DK406484A (fr)
ES (2) ES8607022A1 (fr)
FI (1) FI843285A (fr)
FR (1) FR2551436B1 (fr)
GB (2) GB8324004D0 (fr)
GR (1) GR80204B (fr)
HU (1) HU192430B (fr)
IL (1) IL72749A (fr)
IT (1) IT1180210B (fr)
NL (1) NL8402666A (fr)
NO (1) NO843355L (fr)
NZ (1) NZ209294A (fr)
PT (1) PT79113B (fr)
SE (1) SE8404334L (fr)
SU (1) SU1442070A3 (fr)
ZA (1) ZA846580B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8625326D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Medicaments
US5317032A (en) * 1987-10-02 1994-05-31 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Prostaglandin cathartic
ES2051862T3 (es) * 1987-10-02 1994-07-01 Ueno Seiyaku Oyo Kenkyujo Kk Un metodo para producir un medicamento que tiene un efecto catartico.
AU616564B2 (en) * 1988-09-29 1991-10-31 Sumitomo Chemical Company, Limited Novel pyrazole compounds, method for production thereof, use thereof and intermediates for production thereof
US5099644A (en) * 1990-04-04 1992-03-31 General Electric Company Lean staged combustion assembly
US6680339B2 (en) 1996-11-12 2004-01-20 Alcon Manufacturing, Ltd. 15-fluoro prostaglandins as ocular hypotensives
CA2269855A1 (fr) * 1996-11-12 1998-05-22 Alcon Laboratories, Inc. 15-fluoro prostaglandines utilisees en tant qu'hypotenseurs oculaires
EP1480949B1 (fr) * 2002-03-01 2015-04-29 Allergan, Inc. Preparation de prostamides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987087A (en) * 1971-07-29 1976-10-19 The Upjohn Company Phenyl-substituted prostaglandin-f type analogs
GB1396207A (en) * 1972-04-27 1975-06-04 Upjohn Co Prostaglandin intermediates and the preparation thereof
ZA744581B (en) * 1973-07-20 1975-07-30 Upjohn Co Prostoglandin analogs
US4059576A (en) * 1973-08-06 1977-11-22 Hoffmann-La Roche, Inc. 11-Substituted prostaglandins
GB1484591A (en) * 1974-04-11 1977-09-01 Ono Pharmaceutical Co Prostaglandin compositions
AU501803B2 (en) * 1975-03-21 1979-06-28 Farmitalia Carlo Erba S.P.A. Fluoro-prostaglandins
US4283417A (en) * 1976-06-14 1981-08-11 Pfizer Inc. Bronchodialation with 13,14-dihydro-15-alkenyl prostaglandins
US4268522A (en) * 1976-06-14 1981-05-19 Pfizer Inc. 13,14-Dihydro-15-alkenyl- and 13,14-dihydro-15-alkynyl prostaglandins and analogs thereof

Also Published As

Publication number Publication date
FR2551436A1 (fr) 1985-03-08
DK406484D0 (da) 1984-08-24
HU192430B (en) 1987-06-29
CS259869B2 (en) 1988-11-15
NO843355L (no) 1985-03-08
PT79113B (en) 1986-11-14
DE3430626A1 (de) 1985-04-04
ES8607022A1 (es) 1986-05-16
FI843285A (fi) 1985-03-08
AU562725B2 (en) 1987-06-18
ES8604135A1 (es) 1986-01-16
SE8404334L (sv) 1985-03-08
AU3223184A (en) 1985-03-14
SU1442070A3 (ru) 1988-11-30
PT79113A (en) 1984-09-01
CS636084A2 (en) 1988-04-15
IL72749A0 (en) 1984-11-30
KR850002830A (ko) 1985-05-20
ZA846580B (en) 1985-05-29
GR80204B (en) 1985-01-02
GB2146325A (en) 1985-04-17
IT8422159A0 (it) 1984-08-01
JPS6072859A (ja) 1985-04-24
BE900414A (fr) 1985-02-25
IT1180210B (it) 1987-09-23
GB8421124D0 (en) 1984-09-26
HUT35638A (en) 1985-07-29
ES543776A0 (es) 1986-01-16
IL72749A (en) 1988-05-31
SE8404334D0 (sv) 1984-08-30
NZ209294A (en) 1988-03-30
DK406484A (da) 1985-03-08
GB8324004D0 (en) 1983-10-12
FI843285A0 (fi) 1984-08-20
CH662114A5 (de) 1987-09-15
NL8402666A (nl) 1985-04-01
US4626597A (en) 1986-12-02
GB2146325B (en) 1987-04-01
ES535551A0 (es) 1986-05-16

Similar Documents

Publication Publication Date Title
RO90457A (fr) Procede pour la preparation des n-heterocyclul 4-piperidinamines
RO90414A (fr) Procede pour la preparation des n-heterocyclyle-4-piperidinamines
MA20104A1 (fr) Procede de preparation de dipeptides n-alcoyles et de leurs esters.
FR2376147A1 (fr) Prostaglandines bicycliques, utiles notamment comme anti-agglutinants des plaquettes sanguines et leur procede de preparation
RO82216A (fr) Procede pour la preparation des derives de 3-aryle-5-tsothiazole
IT8027000A0 (it) Procedimento per la produzione di acciai inossidabili.
RO86511A (fr) Procede pour la preparation des beta-lactames
IT8168502A0 (it) Struttura per la confezione singola di assorbenti igienici e metodo per la sua realizzazione
FR2585018B1 (fr) Poly-4-aminopyrrole-2-carboxamides et derives, procede pour leur preparation et leurs utilisations therapeutiques
FR2551436B1 (fr) 16-fluoro-16,17-dideshydro-prostanoides, procede pour leur preparation, produits intermediaires de leur preparation et leurs utilisations therapeutiques, notamment dans les indications des prostaglandines naturelles
RO92931A (fr) Procede cyclique pour la preparation de la solution alcaline de carbamate de cellulose
PT73210A (fr) Procede pour la preparation de benzamides substituees et compositions pharmaceutiques qui les contiennent
BE887324A (fr) Procede de preparation de la relaxine humaine
MA20226A1 (fr) Procede pour la preparation de dipeptides N-alcoyles et de leurs esters.
RO92200A (fr) Procede pour la preparation des s-benzylcarbamates
BE889913A (fr) Cephalosporines substituees, procede pour leur preparation compositions les contenant et leurs utilisations
RO86246A (fr) Procede pour la preparation des 5-(dihydro0ypheno0y)-tetrazoles
BE886997A (fr) Procede de preparation de la ranitidine et produits intermediaires de cette preparation
RO83438A (fr) Procede pour la preparation des bis-tetrazolmethylthioles
BE892602A (fr) Esters de mercaptoacyl-carnitines, procede pour leur preparation et leurs utilisations therapeutiques
RO92966A (fr) Procede pour la preparation des pyrazolines
BE748297A (fr) Enzymes et methode pour la preparation, l'isolement et la purification de ces enzymes
RO82277A (fr) Procede pour la preparation des derives de 11-dodecen-1-yl
FR2527630B1 (fr) Enzyme leucocytaire humaine de type pepsique, procede pour sa preparation et agent therapeutique la contenant
FR2533559B1 (fr) Procede pour la preparation de n-acetyl p-aminophenol

Legal Events

Date Code Title Description
ST Notification of lapse